|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.374
|
Mouse |
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.293
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.285
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.252
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.240
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.240
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.237
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.224
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.219
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.192
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.156
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.154
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.147
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.132
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.128
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.126
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.124
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.117
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.115
|
|
|
|
male germ line sex determination
|
GO:0019100 |
2 |
0.112
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.110
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.108
|
|
|
|
positive regulation of skeletal muscle tissue regeneration
|
GO:0043415 |
4 |
0.104
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.104
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.104
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.101
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.098
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.096
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.096
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.096
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.094
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.090
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.089
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.089
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.085
|
|
|
|
positive regulation of lens epithelial cell proliferation
|
GO:2001111 |
1 |
0.083
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.078
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.078
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.076
|
Mouse |
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.071
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.070
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.070
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.070
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.070
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.069
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.069
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.068
|
|
|
|
negative regulation of endothelial cell apoptotic process
|
GO:2000352 |
7 |
0.068
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.068
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.067
|
|
|
|
positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:0035793 |
1 |
0.066
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.064
|
|
|
|
smooth muscle cell chemotaxis
|
GO:0071670 |
2 |
0.063
|
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.062
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.062
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.060
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.060
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.060
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.059
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.059
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.059
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.059
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.058
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.058
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.058
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.058
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.057
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.055
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.055
|
Mouse |
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.055
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.055
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.054
|
|
|
|
positive regulation of insulin secretion
|
GO:0032024 |
26 |
0.054
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.054
|
|
|
|
positive regulation of metanephric mesenchymal cell migration
|
GO:2000591 |
1 |
0.053
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.053
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.053
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.052
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.052
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.051
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.051
|
|
|
|
regulation of cytokine secretion involved in immune response
|
GO:0002739 |
4 |
0.051
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.050
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.050
|
|
|
|
negative regulation of mesodermal cell fate specification
|
GO:0042662 |
3 |
0.049
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.049
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.048
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.048
|
|
|
|
regulation of hippo signaling
|
GO:0035330 |
1 |
0.048
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.048
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.047
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.047
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.047
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.047
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.047
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.046
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.046
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.045
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.045
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.045
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.045
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.045
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.045
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.044
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.043
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.043
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.043
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.042
|
Mouse |
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.042
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.042
|
|
|
|
detection of mechanical stimulus involved in equilibrioception
|
GO:0050973 |
2 |
0.041
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.041
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.041
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.041
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.041
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.040
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.040
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.040
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.040
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.040
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.040
|
Mouse |
|
|
atrial septum primum morphogenesis
|
GO:0003289 |
3 |
0.039
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.039
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.039
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.039
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.039
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.038
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.038
|
|
|
|
regulation of endothelial cell apoptotic process
|
GO:2000351 |
9 |
0.038
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.038
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.038
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.037
|
|
|
|
positive chemotaxis
|
GO:0050918 |
18 |
0.037
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.037
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.037
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.037
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.036
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.036
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.036
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.036
|
|
|
|
cell migration involved in coronary angiogenesis
|
GO:0060981 |
1 |
0.036
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.035
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.035
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.034
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.034
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.034
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.034
|
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.034
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.034
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.033
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.033
|
Mouse |
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.033
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.033
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.033
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.033
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.033
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.033
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.033
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.032
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.032
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.032
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.032
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.032
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.032
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.032
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.032
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.032
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.031
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.031
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.031
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.031
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.030
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.030
|
Mouse |
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.030
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.030
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.030
|
|
|
|
regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:1900238 |
1 |
0.030
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.030
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.030
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.030
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.030
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.030
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.030
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.030
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.029
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.029
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.029
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.029
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.029
|
|
|
|
intrahepatic bile duct development
|
GO:0035622 |
2 |
0.029
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.029
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.029
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.029
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.029
|
|
|
|
regulation of exit from mitosis
|
GO:0007096 |
1 |
0.029
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.029
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.028
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.028
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.028
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.028
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.028
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.028
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.028
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.028
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.028
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.027
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.027
|
|
|
|
response to heparin
|
GO:0071503 |
1 |
0.027
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.027
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.027
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.027
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.027
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.027
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.027
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.027
|
|
|
|
cell migration involved in vasculogenesis
|
GO:0035441 |
2 |
0.027
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.027
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.027
|
|
|
|
inner cell mass cellular morphogenesis
|
GO:0001828 |
1 |
0.027
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.027
|
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.026
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.026
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.026
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.026
|
|
|
|
positive regulation of peptidyl serine phosphorylation
|
GO:0033138 |
25 |
0.026
|
|
|
|
germ line sex determination
|
GO:0018992 |
3 |
0.026
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.026
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.026
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.026
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.026
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.026
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.026
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.026
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.025
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.025
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.025
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.025
|
Mouse |
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.025
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.025
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.025
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.025
|
|
|
|
cell migration involved in kidney development
|
GO:0035787 |
3 |
0.025
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.025
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.025
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.024
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.024
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.024
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.024
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.024
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.024
|
Mouse |
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.024
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.024
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.024
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.024
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.024
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.024
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.024
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.024
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.024
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.024
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.023
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.023
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.023
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.023
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.023
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.023
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.023
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.023
|
|
|
|
gall bladder development
|
GO:0061010 |
2 |
0.023
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.023
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.023
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.023
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.022
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.022
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.022
|
|
|
|
positive regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014718 |
2 |
0.022
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.022
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.022
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.022
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.022
|
Mouse |
|
|
ascending aorta development
|
GO:0035905 |
3 |
0.022
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.022
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.022
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.022
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.022
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.021
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.021
|
|
|
|
chondrocyte hypertrophy
|
GO:0003415 |
4 |
0.021
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.021
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.021
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.021
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.021
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.021
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.021
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.021
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.021
|
|
|
|
cardiogenic plate morphogenesis
|
GO:0003142 |
1 |
0.021
|
|
|
|
negative regulation of wnt signaling pathway involved in heart development
|
GO:0003308 |
4 |
0.021
|
|
|
|
detection of mechanical stimulus involved in sensory perception of sound
|
GO:0050910 |
16 |
0.021
|
|
|
|
cell aging
|
GO:0007569 |
35 |
0.021
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.021
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.021
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.020
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.020
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.020
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.020
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.020
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.020
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.020
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.020
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.020
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.020
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.020
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.020
|
|
|
|
focal adhesion assembly
|
GO:0048041 |
19 |
0.020
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.020
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.020
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.020
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.019
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.019
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.019
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.019
|
|
|
|
regulation of mesoderm development
|
GO:2000380 |
12 |
0.019
|
|
|
|
adherens junction assembly
|
GO:0034333 |
22 |
0.019
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.019
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.019
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.019
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.019
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.019
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.019
|
|
|
|
regulation of lens epithelial cell proliferation
|
GO:2001109 |
1 |
0.019
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.019
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.019
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.019
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.019
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.019
|
|
|
|
response to muscle stretch
|
GO:0035994 |
1 |
0.019
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.019
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.019
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.019
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.018
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.018
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.018
|
Mouse |
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.018
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.018
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.018
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.018
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.018
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.018
|
|
|
|
endocardium formation
|
GO:0060214 |
4 |
0.018
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.018
|
|
|
|
positive regulation of cytokine secretion involved in immune response
|
GO:0002741 |
2 |
0.018
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.018
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.018
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.018
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.018
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.018
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.018
|
|
|
|
sensory perception of touch
|
GO:0050975 |
2 |
0.018
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.018
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.018
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.018
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.017
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.017
|
|
|
|
erythropoietin mediated signaling pathway
|
GO:0038162 |
1 |
0.017
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.017
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.017
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.017
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.017
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.017
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.017
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.017
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.017
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.017
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.017
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.017
|
|
|
|
cellular response to stem cell factor stimulus
|
GO:0036216 |
3 |
0.017
|
|
|
|
positive regulation of fibroblast growth factor receptor signaling pathway
|
GO:0045743 |
3 |
0.017
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.017
|
|
|
|
cardiac muscle tissue growth involved in heart morphogenesis
|
GO:0003245 |
1 |
0.017
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.017
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.017
|
|
|
|
plasma membrane fusion
|
GO:0045026 |
9 |
0.017
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.017
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.017
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.017
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.017
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.017
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.017
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.017
|
|
|
|
positive regulation of hippo signaling
|
GO:0035332 |
1 |
0.016
|
|
|
|
prostate gland morphogenetic growth
|
GO:0060737 |
4 |
0.016
|
|
|
|
lung smooth muscle development
|
GO:0061145 |
2 |
0.016
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.016
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.016
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.016
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.016
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.016
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.016
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.016
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.016
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.016
|
|
|
|
ascending aorta morphogenesis
|
GO:0035910 |
3 |
0.016
|
|
|
|
regulation of transcription involved in primary germ layer cell fate commitment
|
GO:0060796 |
2 |
0.016
|
|
|
|
negative regulation of striated muscle tissue development
|
GO:0045843 |
18 |
0.016
|
|
|
|
positive regulation of mechanoreceptor differentiation
|
GO:0045633 |
1 |
0.016
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.016
|
Mouse |
|
|
sphingosine 1 phosphate signaling pathway
|
GO:0003376 |
3 |
0.016
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.016
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.016
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.016
|
|
|
|
negative regulation of muscle tissue development
|
GO:1901862 |
20 |
0.016
|
|
|
|
growth involved in heart morphogenesis
|
GO:0003241 |
4 |
0.016
|
|
|
|
protein o linked glycosylation
|
GO:0006493 |
16 |
0.016
|
|
|
|
negative regulation of oxidoreductase activity
|
GO:0051354 |
4 |
0.016
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.016
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.016
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.016
|
|
|
|
dendritic cell cytokine production
|
GO:0002371 |
3 |
0.016
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.016
|
|
|
|
detection of muscle stretch
|
GO:0035995 |
1 |
0.016
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.016
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.016
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.016
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.016
|
|
|
|
kit signaling pathway
|
GO:0038109 |
3 |
0.016
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.016
|
|
|
|
platelet derived growth factor receptor beta signaling pathway
|
GO:0035791 |
4 |
0.015
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.015
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.015
|
|
|
|
epithelial cell proliferation involved in prostatic bud elongation
|
GO:0060517 |
1 |
0.015
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.015
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.015
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.015
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.015
|
|
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
1 |
0.015
|
|
|
|
positive regulation of tor signaling
|
GO:0032008 |
3 |
0.015
|
|
|
|
primary prostatic bud elongation
|
GO:0060516 |
2 |
0.015
|
|
|
|
vascular endothelial growth factor signaling pathway
|
GO:0038084 |
10 |
0.015
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.015
|
Mouse |
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.015
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.015
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.015
|
|
|
|
cardiac myofibril assembly
|
GO:0055003 |
12 |
0.015
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.015
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.015
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.015
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.015
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.015
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.015
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.015
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.015
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.015
|
|
|
|
metanephric glomerular mesangial cell proliferation involved in metanephros development
|
GO:0072262 |
3 |
0.015
|
|
|
|
immune complex clearance by monocytes and macrophages
|
GO:0002436 |
2 |
0.015
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
13 |
0.015
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.015
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.015
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.014
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.014
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.014
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.014
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.014
|
|
|
|
positive regulation of g0 to g1 transition
|
GO:0070318 |
2 |
0.014
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.014
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.014
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.014
|
Mouse |
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.014
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.014
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.014
|
Mouse |
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.014
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.014
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.014
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.014
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.014
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.014
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.014
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.014
|
|
|
|
positive regulation of intracellular protein transport
|
GO:0090316 |
42 |
0.014
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.014
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.014
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.014
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.014
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.014
|
|
|
|
negative regulation of epidermal growth factor activated receptor activity
|
GO:0007175 |
3 |
0.014
|
|
|
|
adipose tissue development
|
GO:0060612 |
25 |
0.014
|
|
|
|
regulation of vasculogenesis
|
GO:2001212 |
9 |
0.014
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.014
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.014
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.014
|
|
|
|
cellular response to fluid shear stress
|
GO:0071498 |
4 |
0.013
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.013
|
|
